KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Shares Outstanding (Weighted Average): 2020-2025

Historic Shares Outstanding (Weighted Average) for Ginkgo Bioworks Holdings (DNA) over the last 5 years, with Sep 2025 value amounting to $59.2 million.

  • Ginkgo Bioworks Holdings' Shares Outstanding (Weighted Average) rose 6.52% to $59.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $59.2 million, marking a year-over-year increase of 6.52%. This contributed to the annual value of $57.5 million for FY2024, which is 8.53% up from last year.
  • As of Q3 2025, Ginkgo Bioworks Holdings' Shares Outstanding (Weighted Average) stood at $59.2 million, which was up 1.14% from $58.5 million recorded in Q2 2025.
  • Ginkgo Bioworks Holdings' Shares Outstanding (Weighted Average)'s 5-year high stood at $59.2 million during Q3 2025, with a 5-year trough of $34.4 million in Q1 2021.
  • Moreover, its 3-year median value for Shares Outstanding (Weighted Average) was $55.3 million (2024), whereas its average is $55.2 million.
  • Data for Ginkgo Bioworks Holdings' Shares Outstanding (Weighted Average) shows a peak YoY skyrocketed of 589.50% (in 2021) over the last 5 years.
  • Ginkgo Bioworks Holdings' Shares Outstanding (Weighted Average) (Quarterly) stood at $37.2 million in 2021, then skyrocketed by 30.49% to $48.5 million in 2022, then rose by 9.20% to $53.0 million in 2023, then climbed by 8.53% to $57.5 million in 2024, then climbed by 6.52% to $59.2 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $59.2 million for Q3 2025, versus $58.5 million for Q2 2025 and $58.0 million for Q1 2025.